Ashley Dalton

I thank the right hon. Member for his statement and questions, and particularly for his personal wishes. Overseeing delivery is absolutely crucial. It is great that we have written a plan, but what matters is delivering it. We started delivery even before we had finished writing this plan; we are not waiting. We have already put £200 million directly into cancer via cancer alliances. We have recruited 2,500 more GPs. We have already put in place 28 cutting edge radiotherapy machines and are rolling out lung cancer screening. We have opened more community diagnostic centres at evenings and weekends. We said we would deliver 2 million more appointments; we have already delivered 5 million more appointments. And we have put £25 million into the National Institute for Health and Care Research’s brain tumour research consortium. Steps are already being taken, but it is really important, as the right hon. Member points out, that we are held to account and that people keep our feet to the fire on delivery. That is why we are setting up a brand new cancer board of charities and clinicians, which will oversee the delivery of this plan and keep our feet to the fire. On workforce, we know how important it is to make sure that the cancer workforce is grown and developed, not only in terms of numbers but in having the resources and the support to use their skills to the utmost. The workforce plan that the Government are developing will also include cancer and will be published this spring. I was delighted to hear the right hon. Member mention rare cancers and children and young people. This is the first ever cancer plan with a chapter on rare cancers, and the first ever cancer plan with a chapter on children and young people, and I am really proud of that. On radiotherapy, as I said, we have invested £70 million into 28 new linear accelerator—LINAC—radiotherapy machines. We have also listened to stakeholders in the radiotherapy community. We are investing in new technology, including those radiotherapy machines, and in AI to assist the oncology workforce to reduce the time it takes to plan and then deliver treatment. By April next year, we will streamline the process to make it easier for radiotherapy centres to use cutting edge stereotactic ablative radiotherapy—SABR—which is crucial to many patients. We will also ensure that the payment system associated with this treatment incentivises rapid adoption. The right hon. Member mentioned hospices, something that I know is very close to his heart and his experience. We are delivering the biggest investment in hospices in a generation. We have provided £100 million to upgrade buildings, facilities and digital systems, and we are giving a further £26 million to children’s and young people’s hospices, ensuring that they can continue offering specialist, compassionate support. More broadly, we are developing a palliative care and end of life modern service framework for England. That is currently being developed alongside our stakeholders, with a planned publication date of autumn 2026. I hope that addresses most of the issues raised by the right hon. Member, but I am more than happy to speak with him further after the debate.